Live Breaking News & Updates on Integrated Discovery Engine

Stay updated with breaking news from Integrated discovery engine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zentalis Pharmaceuticals Announces Inducement Grants Under

NEW YORK and SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company. ....

San Diego , United States , New York , Pharmaceuticals Inc , Zentalis Pharmaceuticals , Zentalis Pharmaceuticals Inc , Compensation Committee Of Zentali Board Directors , Compensation Committee , Zentali Board , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Market , Integrated Discovery Engine , Nasdaq Zntl , Zentalis Pharmaceuticals ,

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

NEW YORK - Zentalis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental. ....

New York , United States , San Diego , Zentalis Pharmaceuticals , Zentalis Pharmaceuticals Inc , Compensation Committee Of Zentali Board Directors , Compensation Committee , Zentali Board , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Market , Integrated Discovery Engine , News Publishing ,

Zentalis Pharmaceuticals Announces Inducement Grants Under

NEW YORK and SAN DIEGO, Oct. 02, 2023 (GLOBE NEWSWIRE) Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company. ....

New York , United States , San Diego , Zentalis Pharmaceuticals , Pharmaceuticals Inc , Zentalis Pharmaceuticals Inc , Compensation Committee Of Zentali Board Directors , Compensation Committee , Zentali Board , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Market , Integrated Discovery Engine , Nasdaq Zntl , Zentalis Pharmaceuticals ,

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.09.2023 - NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting . ....

New York , United States , San Diego , Zentalis Pharmaceuticals Inc , Zentalis Pharmaceuticals , Nasdaq Global Market , Integrated Discovery Engine , Zentalis Pharmaceuticals Chart , Entalis Pharmaceuticals Kurs , Entalis Pharmaceuticals Aktie ,

Zentalis Pharmaceuticals Announces Inducement Grants Under

NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company. ....

San Diego , United States , New York , Zentalis Pharmaceuticals , Pharmaceuticals Inc , Compensation Committee Of Zentali Board Directors , Zentalis Pharmaceuticals Inc , Compensation Committee , Zentali Board , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Market , Integrated Discovery Engine , Nasdaq Zntl , Zentalis Pharmaceuticals ,